Clinical Trial Update: Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the absorption and pharmacodynamic activity of single rising doses of SAR161271 in patients with Type 1 Diabetes Mellitus,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• SAR161271 (SAR161271)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED